IER5は,ガンマ線照射後のHeLa細胞のCdc25B発現を否定的に調節する
Xianzhe Zhao1, Lixin Ding2, Yongzhong Ma3
1The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
BioMed research international
|August 25, 2025
まとめ
即時の早期反応5 (IER5) タンパク質は,ガンマ照射後のHeLa細胞におけるCdc25B発現を否定的に調節する. この発見は,がん放射線治療の感度と結果を理解するために極めて重要です.
科学分野:
- 分子生物学
- 細胞生物学
- 癌 研究
背景:
- 放射線治療は癌治療の基石であり,放射線に対する細胞の感受性が治療の有効性を決定します.
- 放射線に対する細胞反応におけるIER5 (Immediate Early Response 5) タンパク質の役割,特に重要な細胞循環調節体に与える影響は,ほとんど未知のままである.
研究 の 目的:
- ガンマ照射後のHeLa細胞におけるCdc25B発現に対するIER5の影響を調査する.
- IER5 と Cdc25B の間の規制的関係とその細胞サイクル進行への影響を解明する.
主な方法:
- RNA干渉 (RNAi) は,HeLa細胞におけるIER5発現をノックダウンするために使用された.
- 定量的リアルタイムPCR (qRT-PCR) とウェスタン・ブロッティングを用いて,mRNAとタンパク質のレベルを評価した.
- フローサイトメトリーは細胞サイクル分布を分析し,ピアソン相関はIER5-Cdc25B発現関係を評価した.
主要な成果:
- IER5 ノックダウンにより,Cdc25B mRNAとタンパク質発現レベルが著しく変化しました.
- IER5は,Cdc25Bによって制御される G2段階の細胞サイクル分布に影響を与えました.
- IER5とCdc25B発現レベルとの間の負の相関が観察されました.
- IER5の変異は,推定Cdc25B転写レギュレータ:p53,NF- YB,p300の発現に影響した.
結論:
- IER5はガンマ放射線への反応としてCdc25Bの発現を否定的に制御する.
- この調節には,p53,NF- YB,p300を含む転写調節物質との相互作用が含まれる可能性があります.
- IER5-Cdc25B軸の理解は,がんにおける放射線抵抗性メカニズムと潜在的な治療目標についての洞察を提供します.
関連する概念動画
02:37DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:23Negative Regulator Molecules
35.9K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.9K
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
01:24Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K